Michael J. McElhaugh, Chief Business Officer at Arbutus Biopharma Corp (ABUS), sold 20,000 shares at $5.00 ($100K) on 2021-02-09, disclosed to the SEC on 2021-02-10.
Open-market sale of $100k ABUS by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ABUS | SELL | 2020-12-16 | $200K | — | Filing → |
| ABUS | SELL | 2020-07-27 | $100K | — | Filing → |